New drug pricing reform will hurt leading pharmaceutical firms
Published: 2011-11-15 06:59:00
Updated: 2011-11-15 06:59:00
A report released on November 11 said Korea's eight leading drug makers could lose up to 765.5 billion won in revenue and 750.8 billion won in operating income by 2014 if the government’s drug price cut plan goes into effect starting next April.
The eight drug makers include Dong-A, Green Cros...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
